Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes
    • The Product Book

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
    • Content Hubs
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2026 / March / Oral Bacteria Linked to Bone Loss in Mouse Study
Translational Science Translational Science News and Research Clinical

Oral Bacteria Linked to Bone Loss in Mouse Study

Researchers find periodontitis-associated microbiota altered gut metabolism and increased osteoclast activity in mice.

03/16/2026 1 min read

Share

Researchers have reported that salivary microbiota associated with periodontitis influenced bone metabolism in a mouse model of osteoporosis through changes in the gut microbiota and microbial metabolites. The findings were published in the International Journal of Oral Science.

The investigators analyzed salivary microbiota from 21 patients with periodontitis and 17 periodontally healthy donors using 16S ribosomal RNA sequencing. The analysis showed that the periodontitis group had greater microbial diversity and enrichment of periodontal pathogens compared with healthy controls.

To examine systemic effects, the researchers administered pooled salivary microbiota from each group to ovariectomized mice through oral gavage. Using micro-computed tomography and histological analysis, the researchers observed that mice receiving microbiota from patients with periodontitis had lower bone mineral density and deteriorated trabecular architecture compared with mice receiving microbiota from healthy donors. Histological analyses also showed increased numbers of osteoclasts.

Further analyses examined whether gut microbial changes contributed to these skeletal effects. Sequencing of intestinal microbiota showed differences in microbial community composition between groups. Fecal microbiota transplantation experiments indicated that transferring gut microbiota from mice exposed to periodontitis-associated salivary microbiota reproduced bone loss in recipient mice.

Metabolomic analysis of intestinal contents and serum identified differences in metabolic pathways between groups, including reduced activity in tryptophan metabolism. Levels of indole-3-lactic acid (ILA), a metabolite derived from tryptophan, were reduced in mice exposed to periodontitis-associated microbiota.

Laboratory experiments using bone-marrow–derived macrophages showed that ILA inhibited osteoclast differentiation. In additional experiments, oral administration of ILA to mice receiving periodontitis-associated microbiota increased bone density measures and reduced osteoclast numbers.

In a press release, co-author Fuhua Yan said, “[t]his study shows that oral health cannot be viewed in isolation from systemic physiology,” and continued, “[w]e were motivated by the clinical reality that many patients suffer simultaneously from periodontal disease and osteoporosis, yet treatment strategies rarely consider their biological connection.”

“Our findings suggest that targeting gut microbial metabolism could open new preventive and therapeutic avenues in the future,” said co-author Fangfang Sun.

The researchers noted several study limitations, including a limited clinical sample size, and stated that further studies are needed to investigate the underlying mechanisms.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

Related Content

The Analytical Scientist Innovation Awards 2024: #5
Translational Science
The Analytical Scientist Innovation Awards 2024: #5

December 4, 2024

4 min read

Welcome to the 5th ranked Innovation, Pyxis – introduced here by Matterworks co-founder Jack Geremia

The Analytical Scientist Innovation Awards 2024: #4
Translational Science
The Analytical Scientist Innovation Awards 2024: #4

December 5, 2024

6 min read

Thermo Fisher Scientific’s high-sensitivity mass spec for translational omics research – the Stellar MS – is ranked 4th in our annual Innovation Awards

The Analytical Scientist Innovation Awards 2024: #3
Translational Science
The Analytical Scientist Innovation Awards 2024: #3

December 6, 2024

4 min read

Bruker’s multiphoton microscopy module, OptoVolt, ranks third in our Innovation Awards. Here, Jimmy Fong, product development lead, walks us through the major moments during development.

Spit It Out
Translational Science
Spit It Out

December 4, 2024

1 min read

Saliva-based PA-MS test detects paracetamol overdose in just 10 minutes

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.